AzTrials
AzTrials

Colonic PolypCSPVsHSPNCT02717598

Cold Snare Polypectomy Versus Hot Snare Polypectomy for Diminutive and Small Colorectal Polyps

A study testing cold snare polypectomy and hot snare polypectomy in people with Colonic Polyp and Intestinal Polyp, run by Wulumuqi General Hospital of Lanzhou Military Command at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background:The optimal technique for removal of diminutive or small colorectal polyps is debatable. Objective:To compare the complete resection rates of cold snare polypectomy (CSP) and hot snare polypectomy (HSP) for the removal of adenomatous polyps(3-9mm). Design:Prospective randomized controlled study. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Colonic Polyp, Intestinal Polyp
What is being tested?
cold snare polypectomy and hot snare polypectomy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
198 participants
Where
1 siteChina
Study dates
Feb 2016to Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients aged ≥20 years who undergo a screening, surveillance, or diagnostic colonoscopy and are subsequently found to have colorectal polyps measuring 3-9 mm in size
  • Patients who signed an informed consent

Who cannot join

  • patients taking antiplatelet or anticoagulant therapy during the past 1 week of the procedure
  • known coagulopathy
  • history of inflammatory bowel diseases
  • polyposis syndrom
  • Type IV shantian colorectal polyps
  • American Society of Anesthesiology class III or more
  • pregnancy
  • Unable to provide informed consent.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Digestive Disease Center of Wulumuqi General Hospital of Lanzhou Military Command

    Ürümqi, Xinjiang, 830000

Other trials in China

About this study

Official title: Cold Snare Polypectomy Versus Hot Snare Polypectomy for Diminutive and Small Colorectal Polyps: a Randomized Controlled Trial

Background:The optimal technique for removal of diminutive or small colorectal polyps is debatable.

Objective:To compare the complete resection rates of cold snare polypectomy (CSP) and hot snare polypectomy (HSP) for the removal of adenomatous polyps(3-9mm).

Read more

Design:Prospective randomized controlled study. Setting:Three tertiary referral hospitals. Patients:we will recruit a total of 330 polyps(3-9mm). Interventions:Enrolled patients were randomly assigned to one of the two polypectomy protocols (CSP vs. HSP) using a computer-generated random sequence. If a patient had one or more polyps, all eligible polyps were removed using the initially assigned polypectomy protocol. After the initial polypectomy, additional EMR was performed at the polypectomy site to assess the presence of residual polyp tissue.

Main Outcome Measurements:The primary study outcome was to compare the complete polyp resection rate between groups. Secondary outcomes included rate of postpolypectomy adverse events, including bleeding, perforations,infection and rate of tissue retrieval(Complete resection was defined as the absence of residual polyp tissue in the EMR sections of the polypectomy site).

Read the detailed description

1、study objective and Contents

Study objective:

Compare cold snare polypectomy with cold forceps polypectomy with respect to their efficacy and safety for endoscopic resection of small colorectal polyps: a randomized controlled trial.

Study content:

  1. Main Outcome Measurements: The primary study outcome was to compare the complete polyp resection rate between groups. Secondary outcomes included rate of postpolypectomy adverse events, including bleeding, perforations,infection and rate of tissue retrieval(Complete resection was defined as the absence of residual polyp tissue in the EMR sections of the polypectomy site).
  2. Collect the pre-operation and post-operation data of patients who underwent a colonoscopy in the digestive disease center of Wulumuqi General Hospital of Lanzhou Militery Cammand from December 2015. to December 2016.Collect patients clinical data,Laboratory examination data, baseline data.

2、Key technical indicators and Solutions

  1. key technique: After each polypectomy, additional EMR was performed at the polypectomy site, including an additional 1 to 2 mm clear margin, was resected by the snare,to evaluate for the presence of residual polyp tissue.
  2. the implementation of colorectal polypectomy: the polypectomy will be performed by experienced clinician, our Department of Gastroenterology and Hepatology has conducted nearly thousand colorectal polypectomy,and is a national leader in this technology. All the operation done by our team, all the members of our team has been trained to operate according to the operation standardization.All points mentioned above can ensure the smooth implementation of the operation.

3、Research methods and technical routes to be used

  1. The study was a multicenter, prospective,single-blind, randomized controlled study involving patients who underwent a colonoscopy from February 2016 to December 2016. It was conducted according to the Declaration of Helsinki Principles and was approved by the institutional review board of our hospital (2016LL001). The study was reported according to the CONSORT guidelines and was registered at www.clinicaltrials.gov. Written informed consent for this study was obtained from all patients.
  2. Patients: Patients come to the digestive disease center of Wulumuqi General Hospital between 2016.02-2016.12 Inclusion criteria: (1)patients aged >18 years who undergo a screening, surveillance, or diagnostic colonoscopy and are subsequently found to have colorectal polyps measuring 3-9 mm in size.(2) Patients who signed an informed consent.

Exclusion criteria:(1)patients taking antiplatelet or anticoagulant therapy during the past 1 week of the procedure;(2) known coagulopathy;(3) history of inflammatory bowel diseases;(4)polyposis syndrom;(5)Type IV shantian colorectal polyps;(6)American Society of Anesthesiology class III or more;(7) pregnancy;(8)Unable to provide informed consent.

(3)Random method: Enrolled patients were randomly assigned to one of the two polypectomy protocols (CSP vs. HSP) using a computer-generated random sequence. If a patient had one or more polyps, all eligible polyp swere removed using the initially assigned polypectomy protocol. (4)data collection:Laboratory data and previous colonoscopy data.Preoperative baseline data included:Patient entry sequence number,Operation method(CSP or HSP),age,gender, take anticoagulant drugs or not(Warfarin , aspirin, clopidogrel), cause of desease, operation indications(Screening, inspection, polypectomy, fecal occult blood test positive, perianal rectal bleeding, other); Correlation check: 1.Blood routine, urine routine, stool routine + Occult Blood; 2,Liver and kidney function, electrolyte, blood sugar, blood coagulation, blood type, Rh factor, infection disease screening (hepatitis B, hepatitis C, HIV, syphilis and other); 3.Digestive tract tumor marker screening (CA19-9, CA24-2, CEA, etc.); 4.Abdominal ultrasound, electrocardiogram, chest X-ray. The postoperative data were: Bowel preparation (using the Boston Bowel Preparation Scale),Whether to insert the coloscope to the cecum, time of insertion,Whether to send the coloscope to the terminal ileum,Time from the insertion of the coloscope to thececum to Exit the colonoscope. Total time from the insertion of the colon to the exit of the colonoscopy.The number of polyps (per patient), polyp size (mm), anatomical (cecum, ascending colon, transverse colon, hepatic flexure, splenic flexure, descending colon, sigmoid colon, rectum), shape (flat, sessile,pedunculated ) , the number of polyps resected, Whether the naked eye view (NBI) is completely removed, the total operation time,whether the polyps were retrieved, postoperative hemorrhage (postoperative bleeding, hematochezia, delayed bleeding), Whether or not perforate, whether the use of hemostatic clip ( number), pathological diagnosis (tubulovillous adenoma, sessile serrated adenoma, hyperplastic polyp and other non neoplastic polyps), whether the additional EMR success after polypectomy, EMR operation time, the pathological results of EMR tissues (normal intestinal mucosa,tubulovillous adenoma, sessile serrated adenoma, Hyperplastic polyps, other non neoplastic polyps), whether the histological complete resection.

(5) Operation procedure:①Bowel preparation consisted of patients drinking a total of 4 L of polyethylene glycol solution before their procedures.Until the discharge of clean liquid (colorless or yellow transparent water samples). ②Total colonoscopies were prospectively performed by using a high-definition endoscope (CF-H260AL; Olympus Co, Tokyo, Japan) by 7 highly experienced endoscopists. All polyps found during colonoscopy were photographed, and their characteristics, including size,shape and anatomic location, were documented. The size of the polyp was assessed with the width of the biopsy forceps before the polyps were removed. ③Polyps that were deemed neoplastic (vessels surrounding oval, tubular, or branched pits under observation by high-definition white-light endoscopy and narrow-band imaging endoscopy) were subjected to polypectomy. Polyp size was defined by using the opening width of the biopsy forceps. If the size of the polyp was eligible for the study (3-9mm), polypectomy was performed by one of two randomized methods.④ Two kinds of operation methods are adopted: 1.CSP was performed by using a disposable oval snare with a diameter of 10 mm (SD-210U-10; Olympus) under gentle suction to reduce colon wall tension. The tip of the endoscope was deflected toward the polyp base to ensnare 1 to 2 mm of normal mucosa surrounding the polyp.2.HSP, which is using electrocoagulation on the basis of using cold snare.⑤After the polyps were removed, the ulcers were washed with saline lavage fluid. After that, another independent endoscopic surgeon judged whether the endoscopic eradication was successful. ⑥Afterward, additional EMR was performed at the polypectomy site to evaluate for the presence of residual polyp tissue.For histologic assessment of residual polyp tissues, the polypectomy site, including an additional 1 to 2 mm clear margin, was resected by the snare and Endocut current (VIO300D; Erbe Elektromedizin GmbH, Tubingen, Germany) after submucosal injection of a mixed solution (normal saline solution + 0.01% epinephrine). In the event that no tissue could be removed (e.g., if the original resection achieved a wide resection), or if EMR failed to get in situ mucosal specimens. At least four cold biopsies using forceps on the remaining margins were obtained. The primary polyp specimen and the specimen from the base of the polyp were placed in separate jars.⑦After each procedure, the polypectomy site was observed for 30 seconds to confirm the absence of immediate bleeding, the specimens were retrieved and stored in formalin.⑧The retrieved specimen was fixed on a plate by using pins. After indigo carmine solution was applied, the specimen was studied under a stereomicroscope with 8-power magnification to assess the presence of residual tissue by the endoscopist who performed the polypectomy. The presence of residual tissue was documented, and the plate was marked with a pen to indicate the most probable site of residual tissue. Cross-sections of the EMR specimens were collected at 1-mm intervals; accurate tissue section of the marked site was ensured. ⑨All tissue samples were cross-reviewed by 2 experienced pathologists who were blinded to the clinical information. Histological identification was carried out and the comprehensive analysis was carried out. The process is shown in Figure 1. ⑩The patients returned 1 week after each polypectomy to be informed of their pathology results and to be assessed for postprocedural adverse events, such as delayed bleeding. Complete resection was defined as the absence of residual polyp tissue in the EMR sections of the polypectomy site.

(6)Statistical analysis: card square test and Fisher exact test were used to compare categorical variables, the p value less than 0.05 was considered statistically significant, between groups of continuous variables and discrete variables were compared with a two sample t test, or Z test. All the data analysis by SPSS windows system.

(7)sample size estimation: according to Hyun-Soo Kim et al: a randomized controlled study of an GASTROINTESTINAL ENDOSCOPY: cold snare versus hot snare polypectomy for the complete resection of 5-9 mm sized colorectal polyps; a randomized controlled trial, according to the CSP with HSP complete resection rate was (79.1% vs 92.2%), the alpha value of the significant level of 0.05, grasp the degree 1 beta 0.9, according to pass (11.0) software calculated sample size for 300 cases. Taking into account the possible 10% of the rate of loss of access, sample size of 330 cases.

Cold snare polypectomy (CSP) has been shown to be safe and effective for the removal of polyps ≤10 mm in size, and is regarded as the ideal procedure for removal of small polyps. Hot snare techniques for diminutive polypectomy are still popular, but their use has decreased steadily in practice because of limited effectiveness and several drawbacks associated with the use of electrocautery,such as inadequate histologic interpretation and significant risk of complications. However, there have been few randomized controlled trials demonstrating complete resection rate by CSP or HSP for diminutive and small polyps. There are a paucity of data regarding which polypectomy technique is recommended according to polyp size and shape. The polypectomy techniques in the removal of small colorectal polyps in the 3-9 mm size range are not consistent. The study aimed at the direct comparison of the histologic polyp eradication rate of cold snare polypectomy (CSP) with that of hot snare polypectomy (HSP) in 3-9 mm sized flat or sessile colorectal polyps and the efficacy and safety of CSP to HSP in the removal of polyps 3-9 mm in size. In order to guide clinical practice.

Being tested
cold snare polypectomy, hot snare polypectomy
Keywords
cold snare polypectomy, hot snare polypectomy
Medical subject headings
Colonic Polyps, Intestinal Polyps

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cold snare polypectomyProcedure or surgery

    Also called CSP

    CSP was performed by using a disposable oval snare with a diameter of 10 mm under gentle suction to reduce colon wall tension. The tip of the endoscope was deflected toward the polyp base to ensnare 1 to 2 mm of normal mucosa surrounding the polyp. Afterward, additional EMR was performed at the polypectomy site to evaluate for the presence of residual polyp tissue,including an additional 1 to 2 mm clear margin, was resected by the snare and Endocut current after submucosal injection of a mixed solution.In the event that no tissue could be removed or if EMR failed to get in situ mucosal specimens. At least four cold biopsies using forceps on the remaining margins were obtained.After each procedure, the polypectomy site was observed for 30 seconds to confirm the absence of immediate bleeding.Cross-sections of the EMR specimens were collected at 1-mm intervals.

  • hot snare polypectomyProcedure or surgery

    Also called HSP

    HSP, which is using electrocoagulation on the basis of using cold snare.After HSP, another independent endoscopic surgeon judged whether the endoscopic eradication was successful. Afterward, additional EMR was performed at the polypectomy site to evaluate for the presence of residual polyp tissue,including an additional 1 to 2 mm clear margin, was resected by the snare and Endocut current after submucosal injection of a mixed solution.In the event that no tissue could be removed or if EMR failed to get in situ mucosal specimens. At least four cold biopsies using forceps on the remaining margins were obtained.After each procedure, the polypectomy site was observed for 30 seconds to confirm the absence of immediate bleeding, the specimens were retrieved and stored in formalin. Cross-sections of the EMR specimens were collected at 1-mm intervals; accurate tissue section of the marked site was ensured.

Study groups in NCT02717598
Study groupRoleWhat they receive
CSPExperimentalCold snare polypectomy is an easy-to-apply technique and has been the most popular technique esprcially for small and diminutive polyps. Briefly, the endoscopist advances the snare sheath, opens the snare and encircles the polyp. The snare is then slowly and progressively closed, with the aim of capturing 1-2 mm of normal tissue around the polyp, until complete closure is achieved and the polyp is guillotined. The polyp can then be suctioned and retrieved for histologic assessment.
Receives: Procedure: cold snare polypectomy
HSPExperimentalHot snare polypectomy, the endoscopist advances the snare sheath, opens the snare and encircles the polyp. The snare is then slowly and progressively closed, with the aim of capturing 1-2 mm of normal tissue around the polyp,then use Electrocoagulation until complete closure is achieved and the polyp is guillotined. The polyp can then be suctioned and retrieved for histologic assessment.
Receives: Procedure: hot snare polypectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. complete polyp resection rate

    The primary study outcome was to compare the complete polyp resection rate between groups.Complete resection was defined as the absence of residual polyp tissue in the EMR sections of the polypectomy site.

    Measured: one year

Secondary outcomes (1)
  1. rate of postpolypectomy adverse events

    Secondary outcomes included rate of postpolypectomy adverse events, including bleeding, perforations,infection and rate of tissue retrieval

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2016 (estimated)
  2. Study startFeb 2016
  3. Primary completionApr 2017
  4. Study completionJun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
198 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02717598
Sponsor's protocol ID
2016LL001
Acronym
CSPVsHSP
Status last verified
Aug 2017
First submitted
17 Mar 2016
Last updated
30 Aug 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: there is a plan to make individual participant data (IPD) available.

Publications

  • Hewett DG. Colonoscopic polypectomy: current techniques and controversies. Gastroenterol Clin North Am. 2013 Sep;42(3):443-58. doi: 10.1016/j.gtc.2013.05.015.

    PubMed 23931853
  • Kaltenbach T, Soetikno R. Endoscopic resection of large colon polyps. Gastrointest Endosc Clin N Am. 2013 Jan;23(1):137-52. doi: 10.1016/j.giec.2012.10.005. Epub 2012 Oct 30.

    PubMed 23168124
  • Sanchez-Yague A, Kaltenbach T, Raju G, Soetikno R. Advanced endoscopic resection of colorectal lesions. Gastroenterol Clin North Am. 2013 Sep;42(3):459-77. doi: 10.1016/j.gtc.2013.05.012. Epub 2013 Jun 20.

    PubMed 23931854
  • Tolliver KA, Rex DK. Colonoscopic polypectomy. Gastroenterol Clin North Am. 2008 Mar;37(1):229-51, ix. doi: 10.1016/j.gtc.2007.12.009.

    PubMed 18313548
  • Repici A, Hassan C, De Paula Pessoa D, Pagano N, Arezzo A, Zullo A, Lorenzetti R, Marmo R. Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review. Endoscopy. 2012 Feb;44(2):137-50. doi: 10.1055/s-0031-1291448. Epub 2012 Jan 23.

    PubMed 22271024
  • Nakajima T, Saito Y, Tanaka S, Iishi H, Kudo SE, Ikematsu H, Igarashi M, Saitoh Y, Inoue Y, Kobayashi K, Hisasbe T, Matsuda T, Ishikawa H, Sugihara K. Current status of endoscopic resection strategy for large, early colorectal neoplasia in Japan. Surg Endosc. 2013 Sep;27(9):3262-70. doi: 10.1007/s00464-013-2903-x. Epub 2013 Mar 19.

    PubMed 23508817
  • Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370.

    PubMed 22356322
  • Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013 Sep 19;369(12):1106-14. doi: 10.1056/NEJMoa1300720.

    PubMed 24047060
  • Khashab M, Eid E, Rusche M, Rex DK. Incidence and predictors of "late" recurrences after endoscopic piecemeal resection of large sessile adenomas. Gastrointest Endosc. 2009 Aug;70(2):344-9. doi: 10.1016/j.gie.2008.10.037. Epub 2009 Feb 27.

    PubMed 19249767
  • Komeda Y, Suzuki N, Sarah M, Thomas-Gibson S, Vance M, Fraser C, Patel K, Saunders BP. Factors associated with failed polyp retrieval at screening colonoscopy. Gastrointest Endosc. 2013 Mar;77(3):395-400. doi: 10.1016/j.gie.2012.10.007. Epub 2012 Dec 1.

    PubMed 23211749
  • Hassan C, Pickhardt PJ, Kim DH, Di Giulio E, Zullo A, Laghi A, Repici A, Iafrate F, Osborn J, Annibale B. Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopy. Aliment Pharmacol Ther. 2010 Jan 15;31(2):210-7. doi: 10.1111/j.1365-2036.2009.04160.x. Epub 2009 Oct 8.

    PubMed 19814745
  • Pohl H, Srivastava A, Bensen SP, Anderson P, Rothstein RI, Gordon SR, Levy LC, Toor A, Mackenzie TA, Rosch T, Robertson DJ. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013 Jan;144(1):74-80.e1. doi: 10.1053/j.gastro.2012.09.043. Epub 2012 Sep 25.

    PubMed 23022496
  • Gupta N, Bansal A, Rao D, Early DS, Jonnalagadda S, Wani SB, Edmundowicz SA, Sharma P, Rastogi A. Prevalence of advanced histological features in diminutive and small colon polyps. Gastrointest Endosc. 2012 May;75(5):1022-30. doi: 10.1016/j.gie.2012.01.020. Epub 2012 Mar 9.

    PubMed 22405698
  • Pabby A, Schoen RE, Weissfeld JL, Burt R, Kikendall JW, Lance P, Shike M, Lanza E, Schatzkin A. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc. 2005 Mar;61(3):385-91. doi: 10.1016/s0016-5107(04)02765-8.

    PubMed 15758908
  • Robertson DJ, Greenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW, Burke CA, Snover DC, Bresalier RS, McKeown-Eyssen G, Mandel JS, Bond JH, Van Stolk RU, Summers RW, Rothstein R, Church TR, Cole BF, Byers T, Mott L, Baron JA. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology. 2005 Jul;129(1):34-41. doi: 10.1053/j.gastro.2005.05.012.

    PubMed 16012932

Questions about this trial

What is this clinical trial studying?

A study testing cold snare polypectomy and hot snare polypectomy in people with Colonic Polyp and Intestinal Polyp, run by Wulumuqi General Hospital of Lanzhou Military Command at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

complete polyp resection rate (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02717598, which also lists 39 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in